Viking Therapeutics signs broad manufacturing agreement with CordenPharma
Viking Therapeutics (VKTX) announced that it has signed a broad, multi-year manufacturing agreement with CordenPharma, a contract development ...
Harrow executes five-year supply, development agreement for Triesence
Harrow (HROW) announced the execution of a five-year strategic supply and development agreement for Triesence 40 mg/mL, a preservative-free ...
FMC Corp. flags potential hit to supply agreements from U.S.-China trade war
FMC Corp. (NYSE:FMC) finished -2.2% on Friday after disclosing that the deteriorating trade outlook between the U.S. and ...
Harrow Executes Five-Year Strategic Supply and Development Agreement for TRIESENCE®
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced the execution of a five-year ...
Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...